tiprankstipranks
Trending News
More News >
Evolva Holding Sa (CH:EVE)
:EVE
Advertisement

Evolva Holding (EVE) Price & Analysis

Compare
2 Followers

EVE Stock Chart & Stats


EVE FAQ

What was Evolva Holding Sa’s price range in the past 12 months?
Evolva Holding Sa lowest stock price was CHF0.75 and its highest was CHF1.69 in the past 12 months.
    What is Evolva Holding Sa’s market cap?
    Evolva Holding Sa’s market cap is CHF7.68M.
      When is Evolva Holding Sa’s upcoming earnings report date?
      Evolva Holding Sa’s upcoming earnings report date is Feb 20, 2026 which is in 172 days.
        How were Evolva Holding Sa’s earnings last quarter?
        Evolva Holding Sa released its earnings results on Aug 21, 2025. The company reported -CHF0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -CHF0.05.
          Is Evolva Holding Sa overvalued?
          According to Wall Street analysts Evolva Holding Sa’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Evolva Holding Sa pay dividends?
            Evolva Holding Sa does not currently pay dividends.
            What is Evolva Holding Sa’s EPS estimate?
            Evolva Holding Sa’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Evolva Holding Sa have?
            Evolva Holding Sa has 7,230,626 shares outstanding.
              What happened to Evolva Holding Sa’s price movement after its last earnings report?
              Evolva Holding Sa reported an EPS of -CHF0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.455%.
                Which hedge fund is a major shareholder of Evolva Holding Sa?
                Currently, no hedge funds are holding shares in CH:EVE

                Company Description

                Evolva Holding Sa

                Evolva Holding (EVE) is a Swiss-based biotechnology company focused on the research, development, and commercialization of innovative ingredients derived from nature. The company leverages advanced biosynthesis technology to produce high-value compounds for use in various sectors, including food, cosmetics, and personal care. Evolva's core products are sustainable and environmentally friendly alternatives to traditional ingredients, offering enhanced performance and value.

                Evolva Holding (EVE) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Molecular Partners AG
                Newron Pharmaceuticals SpA
                Santhera Pharmaceuticals Holding
                RELIEF THERAPEUTICS Holding
                Xlife Sciences Ltd.

                Ownership Overview

                99.82%
                Insiders
                Mutual Funds
                ― Other Institutional Investors
                99.82% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis